Effects of Blood Products on Inflammatory Response in Endothelial Cells In Vitro by Urner, Martin et al.
Effects of Blood Products on Inflammatory Response in
Endothelial Cells In Vitro
Martin Urner
1,2., Inge K. Herrmann
1,2., Felix Buddeberg
1, Caroline Schuppli
2, Birgit Roth Z’graggen
2,
Melanie Hasler
1, Urs Schanz
3, Manuela Mehr
1, Donat R. Spahn
1, Beatrice Beck Schimmer
1,2*
1Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland, 2Institute of Physiology and Zurich Center for Integrative Human Physiology, University of
Zurich, Zurich, Switzerland, 3Clinic of Haematology, University Hospital Zurich, Zurich, Switzerland
Abstract
Background: Transfusing blood products may induce inflammatory reactions within the vascular compartment potentially
leading to a systemic inflammatory response. Experiments were designed to assess the inflammatory potential of different
blood products in an endothelial cell-based in vitro model and to compare baseline levels of potentially activating
substances in transfusion products.
Methods: Theinflammatory response from pre-activated(endotoxin-stimulated) and non-activated endothelial cells as well as
neutrophil endothelial transmigration in response to packed red blood cells (PRBC), platelet concentrates (PC) and fresh frozen
plasma (FFP) was determined. Baseline inflammatory mediator and lipid concentrations in blood products were evaluated.
Results: Following incubation with all blood products, an increased inflammatory mediator release from endothelial cells
was observed. Platelet concentrates, and to a lesser extent also FFP, caused the most pronounced response, which was
accentuated in already pre-stimulated endothelial cells. Inflammatory response of endothelial cells as well as blood product-
induced migration of neutrophils through the endothelium was in good agreement with the lipid content of the according
blood product.
Conclusion: Within the group of different blood transfusion products both PC and FFP have a high inflammatory potential
with regard to activation of endothelial cells. Inflammation upon blood product exposure is strongly accentuated when
endothelial cells are pre-injured. High lipid contents in the respective blood products goes along with an accentuated
inflammatory reaction from endothelial cells.
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Introduction
Transfusion of blood products is routinely performed in hospitals
on a daily basis. However, with an estimated frequency of
approximately 1 in 5000, blood transfusion leads to an inflamma-
tory state in recipients [1,2]. Transfusion-induced inflammatory
reactions manifests as systemic inflammatory response syndrome,
potentially resulting in severe sepsis [3], failure of pulmonary
function (transfusion related acute lung injury) [4], or multiple
organ failure [5,6,7,8]. Inflammatory responses have been reported
to occur after transfusion of all types of blood components including
whole blood, red blood cells (PRBC), platelet concentrates (PC),
fresh frozen plasma (FFP); with FFP being the most implicated
blood product [9].
It has been previously suggested that the severe inflammatory
reaction within the vascular compartment requires two triggers:
one trigger being the endothelial cell activation (as seen in surgery,
infection, or trauma), followed by a second triggering action
represented by the transfusion of blood products containing
biologic response modifiers aggravating the inflammatory status
[10,11,12,13]. Hence the identification of priming and activating
constituents in the blood products is considered to be of decisive
importance in order to understand pathophysiological mecha-
nisms of endothelial cell activation.
This work aims to assess the inflammatory response of
endothelial cells upon exposure to various types of blood products
such as PRBC, PC (pooled or collected by apheresis), and plasma
(both solvent detergent and untreated FFP). Mimicking a state of
endothelial activation in vitro using lipopolysaccharides (LPS), we
investigated if the inflammatory response and migration of
neutrophils through the endothelial cells layer is accentuated in
pre-activated endothelial cells.
Soluble CD40 ligand (sCD40L) as well as lipids have been
identified as potential biologically active mediators in stored blood
products [14,15,16]. We therefore assessed baseline sCD40L and
total lipid concentration of the blood products and compared the
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previously exposed to the respective blood product. Additionally,
several other inflammatory mediators known to play a crucial role
within the inflammatory orchestration, such as interleukins (IL-6;
IL-8/CXCL8) [17], tissue factor (transforming-growth-factor-b,
TGF-b) [18], and chemokines (monocyte chemoattractant protein-
1, MCP-1/CCL2 [19]; chemokine ligand 1, CXCL1) [20] were
assessed in relation to the blood product’s storage age.
Materials and Methods
The study design was approved by the local Ethic Committee of
the University Hospital Zurich, Switzerland (StV 7-2007).
Blood transfusion products
Aliquotes of 5 mL were taken from the blood products PRBC
(n=56), PC (n=49; 25 pooled, 24 apheresis), solvent detergent
(n=20) or normal FFP (n=50). After centrifugation at 2500 rpm,
the supernatants were aliquoted and stored at 220uC (short-term
storage). In the case of PC, samples were also taken at day 6
(beyond regular storage duration).
Incubation of blood product supernatants with
endothelial cells
Cell culture. Human microvascular endothelial cells
(HMVEC) were cultured as described in [21].
Stimulation with endotoxin. Growth medium of HMVEC
was replaced by EBM-2 medium with 1% FBS 24 hours before
experiments. HMVEC were stimulated with LPS from
Escherichia coli, serotype 055:B5 (Sigma, Buchs, Switzerland) in
a concentration of 2 mg/ml in EBM-2/1% FBS for 6 hrs [22]. As
control group, HMVECs were exposed to phosphate-buffered
saline (PBS) in EBM-2/1% FBS instead of LPS.
Incubation with blood products. Before exposing the pre-
stimulated cells to blood products, the LPS- (or PBS-) containing
medium was removed and cells were washed once with PBS. Cells
were exposed to samples of blood products (20 samples from each
product chosen by random selection using matlabs ‘randi’
function) previously diluted 1:2 in EBM-2/1% FBS, and
supplemented with 12.5 I.E Heparin-Na (B/Braun Medical AG,
Sempach, Switzerland). The control group was incubated with 1:2
diluted PBS with EBM-2/1% FBS and 12.5 I.E Heparin-Na. All
samples were incubated for 24 h at 37.0uC and 5% CO2.
Afterwards, supernatants were collected and stored at 220uC until
further testing by ELISA for IL-6, IL-8, and CXCL1.
Neutrophil transmigration
Neutrophil isolation. Venous blood was obtained from
healthy adult volunteers and anticoagulated with citrate dextrose
solution (Sigma, St. Louis, MO). Neutrophils were isolated by
gradient centrifugation over Ficoll-Paque (Amersham Pharmacia
Biotech, Dubendorf, Switzerland) followed by 1% dextran
sedimentation for 1 h to separate neutrophils from erythrocytes.
Neutrophils were resuspended in Hank’s balanced salt solution
(HBSS; Life Technologies, Carlsbad, CA).
Transmigration assay. Transmigration experiments were
carried out 96-well transmigration chambers (Millipore, Zug,
Switzerland) where the upper compartment is separated from the
lower one by a polycarbonate filtermembrane with pores of 3 mmi n
diameter. After culturing HMVEC in the upper compartment and
prestimulationwithLPS(orPBS),neutrophils (1.5610
6 cells/125 ml
of medium) and blood product (125 ml) were placed in the upper
compartment and incubated at 37uC for 2 h. Transmigrated
neutrophils were then quantified using a glucuronidase assay [23].
In short, cells in the lower compartment were lysed in 1% Triton X-
100, and glucuronidase enzymatic activity was measured by using p-
nitrophenyl-glucuronide (Sigma-Aldrich Chemie, St. Louis, MO) as
a substrate.
Cytokine concentration
Supernatant samples were tested by enzyme-linked immuno-
sorbent assays according to the manufacturer’s protocol for the
following inflammatory mediators: sCD40L, IL-6, IL-8, TGF-b,
MCP-1, and CXCL1 (R&D Systems Europe Ltd, Abingdon, UK).
Optical density was determined at 450 nm and results were given
in pg/ml.
Lipid concentration
For the quantitative determination of the total lipid concentra-
tion in the samples, we used the sulfo-phospho-vanillin colorimet-
ric method [24]. All reagents were purchased from Sigma-Aldrich
(Buchs, Switzerland). Glass tubes were purchased from Vitaris AG
(Baar, Switzerland).
Statistical analysis
Statistical analyses were performed with OriginPro 8G (Origin
Lab, Northampton, MA) and SPSS 17 (SPSS Inc., Chicago, IL).
Boxplot figures show medians and quartiles. Whiskers represent 5%
and 95% confidence intervals, * represent 1% and 99% confidence
intervals. Linear regression was used to assess inflammatory
response in endothelial cells and transendothelial migration of
neutrophils with regard to blood product exposure (dependent
variables:interleukin-6,IL-8,and CXCL1concentrations,migrated
neutrophils; independent variables: type of blood product; Tables
S1, S2, S3, S4). Pearson correlation coefficients were calculated to
determine the correlation of inflammatory response in endothelial
cells and transendothelial migration of neutrophils with baseline
sCD40L and total lipid concentration in blood products (Tables 1
and 2). Spearman’s rank correlation coefficients were calculated to
reveal storage-dependent changes in inflammatory mediator levels
or lipid levels of PRBC or PC (Tables S5 and S6).
Results
Inflammatory response of unstimulated and pre-
stimulated endothelial cells upon incubation with
different blood products
The inflammatory potential of PRBC, PC and FFP was
quantified measuring the inflammatory mediator release from
Table 1. Correlation of inflammatory mediator release in
endothelial cells with baseline sCD40 and lipid concentration
in blood products.
lipids sCD40L
IL-6 Pearson correlation 0.269 20.112
Significance ,0.001 * 0.119
IL-8 Pearson correlation 0.075 20.124
Significance 0.299 0.085
CXCL-1 Pearson correlation 0.146 20.131
Significance 0.042 * 0.069
N=194.
IL-6: interleukin-6; IL-8: interleukin-8; CXCL1: chemokine ligand 1; sCD40L:
soluble CD40 ligand.
doi:10.1371/journal.pone.0033403.t001
Blood Product-Induced Endothelial Inflammation
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different blood transfusion products. As markers of the inflamma-
tory response, de-novo protein synthesis of IL-6, IL-8, and CXCL1
was measured (Fig. 1).
In unstimulated endothelial cells, increased IL-6, IL-8 and
CXCL1 protein levels were found after incubation with different
blood products (at least 2.3-fold (PRBC), 6-fold (PC), 1.5-fold
(FFP), increase relative to control, p,0.001).
Using LPS-stimulated endothelial cells, the cytokine release was
much more pronounced compared to unstimulated cells
(p,0.001). Incubation with PC (both pooled and apheresis)
induced the most accentuated increase in production of mediators
(at least 30-fold increase in cytokine levels relative to LPS)
(p,0.001, results of the linear regressions in Tables S1, S2, S3).
In supernatants from endothelial cells incubated with untreated
FFP, higher cytokine concentrations were found compared to
solvent detergent FFP (2.5-fold higher average cytokine levels in
untreated FFP), however, cytokine concentrations remained well
below the expression levels observed for PC (Tables S1, S2, S3).
Neutrophil transmigration through non-activated and
activated endothelial cell layers
Transmigration of human neutrophils through an unstimulated
and LPS-pre-stimulated endothelial cell layer was assessed (experi-
mental setup Fig. 2A): Similar to the production of inflammatory
mediators upon exposure to blood products, the number of
transmigrated neutrophils was most accentuated for PC and FFP
(Fig. 2B). However, no significant differences in transmigration were
observed between non-stimulated andpre-stimulated endothelialcells
for all blood products, except for PC pooled (p=0.04, Table S4).
Differences in sCD40L and total lipid concentration
among different blood products
A detailed characterization of the used blood products
regarding the inflammatory potential is a pre-requisite regarding
the evaluation and interpretation of the inflammatory response
upon incubation with endothelial cells in the vascular compart-
ment. To obtain a first overview on baseline characteristics of the
different blood products, concentrations of sCD40L protein as a
highly proinflammatory cytokine were measured and compared.
Furthermore total lipid concentration for each blood products was
assessed.
While in PRBC and PC only marginal expression of sCD40L
was found, solvent detergent fresh-frozen plasma showed a
fiftyfold, and untreated FFP hundred times higher sCD40L
concentrations in comparison to PRBC and PC (Fig. 3A). Soluble
CD40L concentrations measured in apheresis PC were not
significantly lower than in pooled PC.
Regarding total lipid levels, the lowest concentrations were
measured in PRBC (median: 0.4 ng/ul), while in apheresis PC and
FFP much higher lipid concentrations (medians: 4.7 ng/ul and
4.4 ng/ul, respectively) were observed (Fig. 3B). A remarkable
difference between lipid concentrations of pooled PC and apheresis
PC was found: The median lipid concentrations measured in
apheresis PC (median: 4.7 ng/ul) was about three times higher than
in pooled PC (median: 1.4 ng/ul). Untreated FFP showed a lipid
concentration of 4.4 ng/ul (median value), whereas in solvent
detergent FFP, lipid concentration (median value 2.2 ng/ul) was
only half of the concentration measured in normal FFP.
Effect of storage time on the concentration of potentially
activating substances present in the blood products
Storage-dependent increase of cytokine concentrations in
packed red blood cells. To evaluate baseline levels of
inflammatory cytokines in blood products, inflammatory
mediators were determined as function of the storage time of the
PRBC (8 days–42 days). In addition to sCD40L, protein levels of
IL-6, IL-8, TGF-b, MCP-1, and CXCL1 were assessed. IL-6, IL-
8, and TGF-b protein concentrations remained below the
detection limits over the whole storage period of 42 days. For
sCD40L, MCP-1 and CXCL1 concentrations, an increase with
storage age was observed (Figure S1, Table S5). The increase in
protein levels is most pronounced at the end of the storage period
after day 36.
No storage-dependent change in cytokine concentrations
in platelet concentrates. The same inflammatory mediators
were also determined for PC as function of storage time. IL-6, IL-
8, and CXCL1 levels remained below the detectable range over
the measured time period up to 6 days. Soluble CD40L, MCP-1,
and TGF-b protein concentrations did not change in an age
dependent manner during the storage period of six days (Figure
S2, Table S5).
Assessment of lipid concentrations in packed red blood
cells and platelet concentrates. To reveal potential storage-
dependent changes in lipid content (breakdown products of
membrane lipids), lipid concentrations were assessed in PRBC
and PC. In PRBC no significant changes were observed over a
storage period of up to 42 days (Spearman’s rank correlation
coefficient: 0.214; p-value: 0.180; Fig. 4 and Table S6).
Regarding pooled and apheresis PC, a storage-age dependent
increase in lipid concentrations after 6 days of storage was found
(Fig. 4 and Table S6). The storage age had no significant
influence on neutrophil transmigration (Table S7).
Correlation of baseline sCD40L and total lipid levels in
blood products on the inflammatory response in
endothelial cells and transendothelial migration
Baseline levels of potential biologic response modifiers such as
sCD40L and total lipids were analyzed regarding their influence
on de novo synthesis of inflammatory mediators in endothelial cells.
No correlation with baseline sCD40L concentration in blood
products was found. The release of IL-6 and CXCL-1 protein was
correlated with baseline total lipid concentration in blood products
(Table 1 and Table S8). This could not be shown for production
of IL-8 protein. Also transendothelial migration was in good
correlation with total lipid levels in blood products, but not with
baseline sCD40L concentrations (Table 2 and Table S9).
Discussion
In the present work, we were able to show that transfusion-
approved PC and to a lesser extent FFP provoke a strong release of
Table 2. Correlation of transendothelial migration of
neutrophils with baseline sCD40L and lipid concentration in
blood products.
Lipids CD40
Transmigration Pearson Korr. 0.707 0.122
Sig. ,0.001 * 0.343
N=62.
sCD40L: soluble CD40 ligand; Transmigration=Transmigration was estimated
measuring glucuronidase enzymatic activity in the lower compartment of the
transmigration chamber.
doi:10.1371/journal.pone.0033403.t002
Blood Product-Induced Endothelial Inflammation
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accentuated in LPS-prestimulated endothelial cells. Secretion of
inflammatory mediator as well as neutrophilic endothelial
transmigration was in good agreement with the lipid content of
the according blood products.
Inflammatory mediator release in pre-activated
endothelial cells in response to blood product exposure
While PRBC lead only to a minor increase in mediator
expression, PC and to a lesser extent FFP induced a strong release
of inflammatory mediators in endothelial cells. This inflammatory
response was even more pronounced when cells were previously
exposed to moderate doses of LPS (‘activated endothelium’). Such
pre-activation of the endothelium may have severe consequences:
blood products can induce an extra production of inflammatory
mediators in activated compared to non-activated endothelial cells.
Differences in inflammatory potential among the different blood
components were found regarding stimulation of the endothelial
cells. Plasma-rich components and platelets appear to be particu-
larly active with regard to the endothelial inflammatory mediator
secretion, which in turn raises questions about biological response
modifiers [25] present in the respective blood components (baseline
levels) and their storage time dependent accumulation. Although
variations in inflammatory response were observed for different
bags of the same blood product, the importance was clearly
secondary to the observed differences among transfusion products.
Differences in mediator levels among different blood
products and storage-dependent accumulation of
biologically active mediators
No time-dependent changes in cytokine concentration up to 35
days of storage were found in leukocyte-reduced PRBC, however,
after 35 days, a slight increase in concentration of sCD40L, MCP-
1, and CXCL1 was measured. In leukocyte-reduced PC we did
not find any change in cytokine concentration over storage time.
This is in accordance with other studies, showing that accumu-
lation of cytokines in blood products could be prevented by pre-
storage leukocyte-reduction [26,27,28,29,30]. Interestingly, cyto-
kine concentrations vary widely among different units of
leukocyte-depleted products, suggesting that the cytokines origi-
nate from time points before leukocyte-reduction. Indeed,
Chudziak et al. [31] found a strong correlation between cytokine
concentration and time of leukocyte-reduction in blood products.
In conclusion, high cytokine concentrations seem to be rather a
result of late leukocyte removal during blood product manufac-
turing than of prolonged storage time.
With regard to lipid concentration no increase was observed for
PRBC between 8 and 42 days. While the concentration was low in
the pooled PC products and remained at this level for 6 days,
higher concentrations of lipids were measured in the apheresis PC
with an increase over time. If this observation is due to the
Figure 1. Inflammatory reaction of endothelial cells in
response to exposure to different blood products. Concentra-
tions of interleukin-6, IL-6 (A), interleukin-8 (IL-8) (B) as well as
chemokine ligand 1 CXCL1 (C) in supernatants of human microvascular
endothelial cells (HMVEC). HMVEC were stimulated with lipopolysac-
charide (LPS) 2 mg/ml for 6 h (pre-stimulated) or not (unstimulated),
followed by an 24 h-incubation with the according blood products
packed red blood cells (PRBC), platelet concentrates (PC), pooled or
apheresis, and solvent detergent or untreated fresh frozen plasma (FFP).
Supernatants were collected and IL-6, IL8 and CXCL1 were determined.
Results are shown as medians with interquartile ranges.
doi:10.1371/journal.pone.0033403.g001
Blood Product-Induced Endothelial Inflammation
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in vitro study has found impaired function of PC after a storage
time exceeding 7 days [32]. Additionally, Schrezenmeier et al
mentioned in a recent review article, that several factors might
influence the quality of PC such as extent of cell separation
(residual leukocytes), plasma content or additive solution which in
turn might affect also lipid concentration of PC [33].
PMN transmigration is correlated to inflammatory
response but independent on pre-activation of
endothelial cells
Effector cell infiltration and migration through the endothelium
orchestrated by proinflammatory mediators and chemoattractants
secreted from endothelial cells is a crucial step in the evolvement of
tissue damage [34]. We quantitatively assessed the number of
polymorphonuclear neutrophils transmigrating through an endo-
thelial cell monolayer in the presence of different blood products.
Transmigration might reflect an active process of the neutrophils
triggered by the release of chemoattractant inflammatory
mediators, secreted by already transmigrated neutrophils. Alter-
natively, a passive transmigration due to a neutrophil-induced
destruction of the endothelial monolayer with increased perme-
ability might be observed. Indeed, the number of transmigrated
neutrophils was in good agreement with the observed relative
inflammatory mediator secretion: neutrophil migration was most
accentuated in the presence of PC and FFP. Interestingly,
neutrophil net migration was, however, unaffected by the LPS
priming of the endothelial cell layer. This stays in contrast to the
amplified inflammatory cytokine expression observed for pre-
activated endothelial cells.
Figure 3. sCD40L protein and total lipid concentrations in
different blood products. Concentration of soluble CD40 ligand
(sCD40L) (A) and total lipids (B) in packed red blood cells (PRBC),
platelet concentrates (pooled and apheresis), solvent detergent or
untreated fresh frozen plasma (FFP). Blood products were collected and
centrifuged at 1500 rpm. Supernatants were analyzed with enzyme-
linked immunosorbent assays for sCD40L, concentrations of lipids were
determined using the sulfo-vanillin colorimetric method. Results are
shown as medians with interquartile ranges.
doi:10.1371/journal.pone.0033403.g003
Figure 2. Neutrophil transmigration through an endothelial
cell layer after exposure to blood products. Transmigration of
neutrophils through unstimulated and pre-stimulated monolayer of
human microvascular endothelial cells (HMVEC) (A). HMVEC were
stimulated with lipopolysaccharide (LPS) 2 mg/ml for 6 h (pre-stimulat-
ed) or not (unstimulated), followed by a 2 h-incubation with the
according supernatant of previously centrifuged blood products such
as packed red blood cells (PRBC), platelet concentrates (PC), pooled or
apheretic, and solvent detergent or untreated fresh frozen plasma (FFP)
together with 1.5610
6 neutrophils. Transmigrated neutrophils were
measured using a glucuronidase assay (B). Results are shown as
medians with interquartile ranges.
doi:10.1371/journal.pone.0033403.g002
Blood Product-Induced Endothelial Inflammation
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based on concentration of sCD40L and/or total lipid?
As differences in sCD40L and lipid concentrations among the
different types of blood products were observed, inflammatory
response of endothelial cells as well as transendothelial effector cell
migration were compared to the measured baseline sCD40L and
total lipid concentrations in blood products. An identical pattern of
lipid levels and inflammatory mediator release was found: while
the lipid levels and the observed inflammatory response in PRBC
were moderate, the lipid as well as the inflammatory mediator
levels reached their maximum for PC products. In agreement with
our results, a recent study showed that lysophosphatidylcholines in
PC might contribute to pulmonary inflammation [35]. Also
nonpolar lipids in PRBC are thought to play a certain role in the
inflammation process [36].
Limitations of the used experimental approach
In contrast to the raise in proinflammatory mediators after
incubation with blood products measured in the present
endothelial cell model, only few patients develop severe inflam-
matory reactions upon blood product administration. It is believed
that in patients, there is a complex balance between pro- and anti-
inflammatory factors which ultimately determines the reaction of
the patient in response to blood product transfusion wherein the
state of pre-activation in endothelial cells plays an important role.
However, in vitro models may only replicate a specific part of such
complex reactions. In addition, in this in vitro model, endothelial
cells were studied under static and isolated conditions which do
not accurately mimic the dynamic response of a whole organism to
blood transfusion. In the present study, experiments were
performed using blood products ready for transfusion received
from the hospital’s blood bank. To the best of our knowledge,
unprocessed fresh blood is not readily used for transfusion and was
therefore not considered to be of relevance in this study.
Beside stimulation using lipopolysaccharides there are several
other potent activators (such as TNF-a or interleukin-1 beta) of
endothelial cells [37]. The use of lipopolysaccharides to provoke
the release of proinflammatory mediators is very well established
and has been described in cell and animal models, as well as in
human volunteers [38,39,40].
Conclusion and outlook
This work compares for the first time the inflammatory response
in endothelial cells upon exposure to all important blood products
in the same setting. Blood products are able to provoke an
inflammatory response in endothelial cells, especially when cells
are already pre-activated. Platelet concentrates appear to be more
potent than FFP as trigger for the inflammatory reaction within
the vascular compartment.
As the inflammatory reaction most likely goes along with lipid
content of the blood products, further investigations are now
needed to quantitatively analyze the lipid content in PC and FFP.
Detailed elucidation of the lipid composition of blood product may
crystallize factors to be removed from these two blood products
leading to safer blood transfusion for the patients.
While several studies in the recent years have put major efforts
in finding causative factors for blood product-induced inflamma-
tory conditions in patients, the key compound responsible has not
yet been identified. However, based on the above presented
results, we hypothesize that lipids - causative or not - may
represent a surrogate for the inflammatory potential of the blood
product. This has now to be investigated in future in vivo
experiments.
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